Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
10751
CALL
UroGen Pharma
URGN
$1.74B
| $124K | ﹤0.01% |
9,800
-15,200
| -61% | -$226K |
2022 Q3
8 quarters
|
|
10752
PUT
iShares Residential and Multisector Real Estate ETF
REZ
$767M
| $124K | ﹤0.01% |
1,400
-1,200
| -46% | -$100K |
2021 Q3
12 quarters
|
|
10753
Rush Enterprises Class A
RUSHA
$5.24B
| $124K | ﹤0.01% |
3,527
-186,403
| -98% | -$6.16M |
2024 Q1
2 quarters
|
|
10754
PUT
Driven Brands
DRVN
$1.94B
| $124K | ﹤0.01% |
8,700
-18,300
| -68% | -$251K |
2022 Q4
7 quarters
|
|
10755
US Global Investors
GROW
$35.7M
| $124K | ﹤0.01% |
48,053
+31,471
| +190% | +$81.5K |
2021 Q1
14 quarters
|
|
10756
Northern Trust
NTRS
$30.6B
| $124K | ﹤0.01% |
1,377
-59,821
| -98% | -$5.23M |
2021 Q3
12 quarters
|
|
10757
Evolution Petroleum
EPM
$145M
| $124K | ﹤0.01% |
23,289
-23,858
| -51% | -$126K |
2024 Q2
1 quarter
|
|
|
AIM
10758
AIM ImmunoTech
AIM
$7.19M
| $124K | ﹤0.01% |
4,582
+3,601
| +367% | +$120K |
2024 Q2
1 quarter
|
|
10759
PUT
iShares Micro-Cap ETF
IWC
$1.31B
| $123K | ﹤0.01% |
+1,000
| New | +$121K |
2024 Q3
0 quarters
|
|
10760
PUT
Westlake Chemical Partners
WLKP
$751M
| $123K | ﹤0.01% |
5,500
+900
| +20% | +$20.4K |
2022 Q3
8 quarters
|
|
|
VMEO
10761
CALL
DELISTED
Vimeo
VMEO
| $123K | ﹤0.01% |
24,400
-9,800
| -29% | -$44.5K |
2021 Q2
13 quarters
|
|
|
EWCZ
10762
PUT
DELISTED
European Wax Center
EWCZ
| $123K | ﹤0.01% |
18,100
+16,300
| +906% | +$127K |
2022 Q3
8 quarters
|
|
|
OBE
10763
Obsidian Energy
OBE
$737M
| $123K | ﹤0.01% |
+22,191
| New | +$149K |
2024 Q3
0 quarters
|
|
10764
CALL
ProShares Short Financials
SEF
$17.9M
| $123K | ﹤0.01% |
3,225
-11,500
| -78% | -$457K |
2023 Q4
3 quarters
|
|
10765
CALL
Amer Sports
AS
$15.7B
| $123K | ﹤0.01% |
7,700
+7,200
| +1,440% | +$92.1K |
2024 Q1
2 quarters
|
|
10766
PUT
Immunome
IMNM
$2.19B
| $123K | ﹤0.01% |
8,400
-14,700
| -64% | -$209K |
2023 Q1
6 quarters
|
|
10767
PUT
Acumen Pharmaceuticals
ABOS
$148M
| $123K | ﹤0.01% |
49,500
+17,000
| +52% | +$46.1K |
2023 Q2
5 quarters
|
|
|
WAY
10768
PUT
Waystar Holding Corp
WAY
$4.97B
| $123K | ﹤0.01% |
+4,400
| New | +$109K |
2024 Q3
0 quarters
|
|
10769
Aware
AWRE
$22.5M
| $123K | ﹤0.01% |
65,577
-10,347
| -14% | -$21.7K |
2024 Q1
2 quarters
|
|
10770
CALL
Actinium Pharmaceuticals
ATNM
$34.3M
| $123K | ﹤0.01% |
65,200
+39,700
| +156% | +$157K |
2020 Q4
15 quarters
|
|
10771
CALL
OFS Capital
OFS
$56.3M
| $123K | ﹤0.01% |
14,500
-3,300
| -19% | -$27.7K |
2022 Q1
10 quarters
|
|
|
LOAN
10772
Manhattan Bridge Capital
LOAN
$40.2M
| $122K | ﹤0.01% |
21,956
-4,005
| -15% | -$21.1K |
2024 Q1
2 quarters
|
|
10773
CALL
ProShares Short QQQ
PSQ
$578M
| $122K | ﹤0.01% |
3,100
-9,360
| -75% | -$386K |
2022 Q1
10 quarters
|
|
10774
CALL
Clean Energy Fuels
CLNE
$339M
| $122K | ﹤0.01% |
39,300
+14,600
| +59% | +$41.4K |
2020 Q1
18 quarters
|
|
|
CCC
10775
CCC Intelligent Solutions
CCC
$3.79B
| $122K | ﹤0.01% |
11,059
-3,891,845
| -100% | -$42M |
2022 Q2
9 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.